z-logo
Premium
Angiotensin‐converting enzyme inhibitory and antioxidant peptides from digestion of larvae and pupae of Asian weaver ant, Oecophylla smaragdina , Fabricius
Author(s) -
Pattarayingsakul Werawich,
Nilavongse Arjaree,
Reamtong Onrapak,
Chittavanich Pamorn,
Mungsantisuk Idsada,
Mathong Yuvadee,
Prasitwuttisak Wipoo,
Panbangred Watanalai
Publication year - 2017
Publication title -
journal of the science of food and agriculture
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 142
eISSN - 1097-0010
pISSN - 0022-5142
DOI - 10.1002/jsfa.8155
Subject(s) - abts , trypsin , antioxidant , biochemistry , peptide , chemistry , dpph , enzyme , proteolytic enzymes , digestion (alchemy) , biology , food science , chromatography
BACKGROUND Mixed larvae and pupae of weaver ant ( Oecophylla smaragdina ) are widely used as an important food ingredient in regions of Thailand. They have high nutritional values and comprise 53% protein and 13% lipid. Peptides derived from food proteins have been shown to possess biological activities. RESULTS Peptides derived from pepsin and trypsin digestion of these weaver ant larvae and pupae were purified based on angiotensin‐converting enzyme ( ACE ) inhibitory and antioxidant activities, and their amino acid sequences were identified by liquid chromatography–tandem mass spectrometry ( LC‐MS / MS ). In silico docking of peptides with ACE successfully predicted the inhibitory peptides as confirmed by their chemical synthesis. Two peptides with sequences of FFGT and LSRVP showed IC 50 values for ACE inhibition of 19.5 ± 1.7 and 52.7 ± 4.0 µmol L −1 , respectively. In addition, one potent antioxidant peptide with a sequence of CTKKHKPNC showed IC 50 values of 48.2 ± 2.1 µmol L −1 for DPPH assay and 38.4 ± 0.2 µmol L −1 for ABTS assay, respectively. CONCLUSION These results indicate that proteins from larvae and pupae of weaver ants are potential sources of peptides with anti‐ ACE and antioxidation bioactivities. © 2016 Society of Chemical Industry

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here